1.
|
Series No.:
|
951
|
2.
|
Aggregate Principal
Amount:
|
U.S.$20,000,000
|
3.
|
Issue Price:
|
U.S.$20,000,000, which is 100.00
percent of the Aggregate Principal Amount
|
4.
|
Issue Date:
|
November 20, 2024
|
5.
|
Form of Notes
(Condition 1(a)):
|
Registered only
|
6.
|
New Global Note:
|
No
|
7.
|
Authorized Denomination(s)
(Condition 1(b)):
|
U.S.$200,000 and integral multiples
thereof
|
8.
|
Specified Currency
(Condition 1(d)):
|
United States Dollars (U.S.$) being
the lawful currency of the United States of America
|
9.
|
Specified Principal Payment
Currency
(Conditions 1(d) and 7(h)):
|
U.S.$
|
10.
|
Specified Interest Payment
Currency
(Conditions 1(d) and 7(h)):
|
U.S.$
|
11.
|
Maturity Date
(Condition 6(a); Fixed Interest Rate and Zero Coupon):
|
November 20, 2034
|
12.
|
Interest Basis
(Condition 5):
|
Fixed Interest Rate (Condition
5(I))
|
13.
|
Interest Commencement Date
(Condition 5(III)):
|
Issue Date (November 20,
2024)
|
14.
|
Fixed Interest Rate (Condition
5(I)):
|
|
|
(a) Interest Rate:
|
5.10 percent per annum
|
|
(b) Fixed Rate Interest Payment
Date(s):
|
Annually in arrear on November 20 in
each year, commencing on November 20, 2025, up to and including the
Maturity Date.
Each Fixed Rate Interest Payment
Date is subject to the Business Day Convention, but with no
adjustment to the amount of interest otherwise
calculated.
|
|
(c) Business Day
Convention:
|
Following Business Day
Convention
|
|
(d) Fixed Rate Day Count
Fraction(s):
|
30/360
|
15.
|
Relevant Financial
Center:
|
New York
|
16.
|
Relevant Business Days:
|
New York
|
17.
|
Issuer's Optional Redemption
(Condition 6(e)):
|
Yes, in whole but not in
part
|
|
(a) Notice Period:
|
No less than five (5) Relevant
Business Days prior to the Optional Redemption Dates
|
|
(b) Amount:
|
100.00 percent per Authorized
Denomination
|
|
(c) Date(s):
|
November 20 in each year, commencing
on November 20, 2026, up to and including November 20,
2033.
|
|
(d) Early Redemption Amount
Bank:
|
100.00 percent of the Aggregate
Principal Amount
|
18.
|
Redemption at the Option of the
Noteholders (Condition 6(f)):
|
No
|
19.
|
Governing Law:
|
New York
|
Other Relevant Terms
|
1.
|
Listing:
|
None
|
2.
|
Details of Clearance System Approved
by the Bank and the
Global Agent and Clearance and
Settlement Procedures:
|
Euroclear Bank SA/NV; Clearstream
Banking S.A.
|
3.
|
Syndicated:
|
No
|
4.
|
Commissions and
Concessions:
|
No commissions or concessions are
payable in respect of the Notes. An affiliate of the Dealer has
arranged a swap with the Bank in connection with this transaction
and will receive amounts thereunder that may comprise
compensation.
|
5.
|
Estimated Total Expenses:
|
The Dealer has agreed to pay for all
material expenses related to the issuance of the Notes.
|
6.
|
Codes:
|
|
|
(a) ISIN:
|
XS2937306871
|
|
(b) Common Code:
|
293730687
|
7.
|
Identity of Dealer:
|
J.P. Morgan Securities
plc
|
8.
|
Provision for Registered
Notes:
|
|
|
(a) Individual Definitive
Registered Notes Available on Issue Date:
|
No
|
|
(b) DTC Global Note(s):
|
No
|
|
(c) Other Registered Global
Notes:
|
Yes, issued in accordance with the
Amended and Restated Global Agency Agreement, dated as of July 28,
2020, between the Bank, Citibank, N.A., London Branch as Global
Agent, and the other parties thereto.
|
9.
|
Intended to be held in a manner
which would allow Eurosystem eligibility:
|
Not Applicable
|
10.
|
Selling Restrictions:
(a) United
States:
|
Under the provisions of Section
11(a) of the Inter-American Development Bank Act, the Notes are
exempted securities within the meaning of Section 3(a)(2) of the
U.S. Securities Act of 1933, as amended, and Section 3(a)(12) of
the U.S. Securities Exchange Act of 1934, as amended.
|
|
(b) United
Kingdom:
|
The Dealer represents and agrees
that (a) it has only communicated or caused to be communicated and
will only communicate or cause to be communicated an invitation or
inducement to engage in investment activity (within the meaning of
Section 21 of the Financial Services and Markets Act 2000 (the
"FSMA")) received by it in connection with the issue or sale of the
Notes in circumstances in which Section 21(1) of the FSMA does not
apply to the Bank, and (b) it has complied and will comply with all
applicable provisions of the FSMA with respect to anything done by
it in relation to such Notes in, from or otherwise involving the
UK.
|
|
(c) Singapore:
|
In the case of the Notes being
offered into Singapore in a primary or subsequent distribution, and
solely for the purposes of its obligations pursuant to Section 309B
of the Securities and Futures Act (Chapter 289) of Singapore (the
"SFA"), the Issuer has determined, and hereby notifies all relevant
persons (as defined in Section 309A of the SFA) that the Notes are
"prescribed capital markets products" (as defined in the Securities
and Futures (Capital Markets Products) Regulations 2018 of
Singapore) and Excluded Investment Products (as defined in MAS
Notice SFA 04-N12: Notice on the Sale of Investment Products and
MAS Notice FAA-N16: Notice on Recommendations on Investment
Products).
|
|
(d) General:
|
No action has been or will be taken
by the Issuer that would permit a public offering of the Notes, or
possession or distribution of any offering material relating to the
Notes in any jurisdiction where action for that purpose is
required. Accordingly, the Dealer agrees that it will observe
all applicable provisions of law in each jurisdiction in or from
which it may offer or sell Notes or distribute any offering
material.
|